Revolution Medicines (RVMD) · RAS(ON) inhibitor combinations
Narrower window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: 2026
We currently expect to provide updated combination data in CRC in 2026.
· filed · SEC filing
After
Stated timing: fourth quarter of 2026
We currently expect to provide updated combination data in CRC in the fourth quarter of 2026.
10-Q · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/RVMD-ras-on-inhibitor-combinations-2026-08-05, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/RVMD-ras-on-inhibitor-combinations-2026-08-05
Revolution Medicines (RVMD) pipeline and stated timing · Calendar · Companies A–Z
A Form 10-Q is a company’s quarterly report to the SEC, with unaudited financial statements.